𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled, Phase 2 study to evaluate the clinical efficacy, safety and tolerability of ARX-03 sublingual Sufentanil/Triazolam NanoTabs in patients undergoing an elective abdominal liposuction procedure

✍ Scribed by N. Singla; S. Lakshman; P. Palmer


Book ID
118477319
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
34 KB
Volume
12
Category
Article
ISSN
1528-8447

No coin nor oath required. For personal study only.